Zura Bio (ZURA)

• Market cap: $628M
• 1 day: -2.22%
• 5 days: 8.35%
• 1 month: 2.95%
• 3 months: 72.4%
• 6 months: 206.48%
• Year to date: 19.28%
• 1 year: 451.67%
• 5 years: -31.75%
• 10 years: -31.75%
• Sector: Healthcare
• Industry: Biotechnology

About: Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Employees: 30